Skip to main content
Heart Lung > Contact

Amy Ferketich

Office Information

B209 Starling-Loving Hall
320 West 10th Ave
Columbus, OH, 43210
Office Phone: (614) 293-4387

Lab Information

473 West 12th Ave
Columbus, OH, 43210

Area of Expertise

Dr. Ferketich is primarily interested in tobacco control research. She is currently collaborating with investigators at the Charles B. Wang Community Health Center in Chinatown, New York City on projects that involve smoking prevention and smoking cessation. She is also a co-investigator on the NCI-funded P50 Population Health and Health Disparities Center grant at OSU, which is focused on cervical cancer among women in the Appalachian region in Ohio (PI: Dr. Electra Paskett). Dr. Ferketich is working with Dr. Mary Ellen Wewers, the PI on the smoking cessation intervention study contained within this Center. Dr. Ferketich is also collaborating with Dr. Wewers on a second smoking cessation project targeting male and female smokers in Appalachia. This study is funded through the Biomedical Research and Technology Transfer research program on lung cancer (PI: Dr. Michael Caligiuri).

A second research interest is cancer among the Amish, including incidence and risk factors. Dr. Ferketich has worked on a project that involves estimating cancer incidence rates and lifestyle factors related to cancer among the Amish in Holmes County, Ohio.

Interest and Subspecialty

Epidemiology and biostatistics, tobacco control.

Recent Publications

Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, and Caligiuri MA. S elective efficacy of Depsipeptide in a xenograft model of Epstein-Barr virus- positive lymphoproliferative disorder. Journal of the National Cancer Institute, 96:1447-1457, 2004.

Roychowdhury S, May KF, Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y, Caligiuri MA. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low dose interleukin 15 but not low dose interleukin 2. Cancer Research, 64:8062-8067, 2004.

Blaser BW, Roychowdhury S, Kim DJ, Schwind NR, Bhatt D, Yuan W, Kusewitt DF, Ferketich AK, Caligiuri MA, Guimond M. Donor derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood, 105:894-901, 2005.


Contact Us





473 W. 12th Ave.
Columbus, OH 43210

Get Directions

Ferketich, Amy